{"title":"小鼠汞诱导的免疫复合物疾病:环磷酰胺治疗的效果和t细胞的重要性。","authors":"P Hultman, S Eneström","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The renal immune-complex (IC) disease induced in BALB/c mice by subcutaneous injection of mercuric chloride (1.6 mg/kg b.w.) every third day for 8 weeks was prevented by the intraperitoneal injection of cyclophosphamide (20 mg/kg b.w.) 24 h prior to mercury injection. The importance of T-cells in the induction of immune-complex disease was studied. BALB/c mice given drinking water containing 20 mg/l of HgCl2 for 10 weeks showed an increased titre of granular, mesangial IgG deposits and vessel wall IgG deposits. Identically treated, congenic nude BALB/c mice with a similar body burden of mercury developed no IC-disease. Cytophotometric analysis of the T-cell subsets in subcutaneously mercury-treated mice revealed a decrease in the fraction of T-helper (L3T4+) splenic cells in the SJL and C57BL/6J strains; no significant change in the T-cell subsets was found in BALB/c mice. C57BL/6J mice, resistant to induction of IC-disease by mercury, showed no increase in the fraction of T-suppressor/cytotoxic (Lyt-2+) cells and no change in the T-helper/T-suppressor cell ratio. C57BL/6J mice could not be rendered susceptible to mercury-induced IC-disease by treatment with different doses of cyclophosphamide.</p>","PeriodicalId":9248,"journal":{"name":"British journal of experimental pathology","volume":"70 3","pages":"227-36"},"PeriodicalIF":0.0000,"publicationDate":"1989-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040569/pdf/brjexppathol00147-0005.pdf","citationCount":"0","resultStr":"{\"title\":\"Murine mercury-induced immune-complex disease: effect of cyclophosphamide treatment and importance of T-cells.\",\"authors\":\"P Hultman, S Eneström\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The renal immune-complex (IC) disease induced in BALB/c mice by subcutaneous injection of mercuric chloride (1.6 mg/kg b.w.) every third day for 8 weeks was prevented by the intraperitoneal injection of cyclophosphamide (20 mg/kg b.w.) 24 h prior to mercury injection. The importance of T-cells in the induction of immune-complex disease was studied. BALB/c mice given drinking water containing 20 mg/l of HgCl2 for 10 weeks showed an increased titre of granular, mesangial IgG deposits and vessel wall IgG deposits. Identically treated, congenic nude BALB/c mice with a similar body burden of mercury developed no IC-disease. Cytophotometric analysis of the T-cell subsets in subcutaneously mercury-treated mice revealed a decrease in the fraction of T-helper (L3T4+) splenic cells in the SJL and C57BL/6J strains; no significant change in the T-cell subsets was found in BALB/c mice. C57BL/6J mice, resistant to induction of IC-disease by mercury, showed no increase in the fraction of T-suppressor/cytotoxic (Lyt-2+) cells and no change in the T-helper/T-suppressor cell ratio. C57BL/6J mice could not be rendered susceptible to mercury-induced IC-disease by treatment with different doses of cyclophosphamide.</p>\",\"PeriodicalId\":9248,\"journal\":{\"name\":\"British journal of experimental pathology\",\"volume\":\"70 3\",\"pages\":\"227-36\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040569/pdf/brjexppathol00147-0005.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British journal of experimental pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of experimental pathology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Murine mercury-induced immune-complex disease: effect of cyclophosphamide treatment and importance of T-cells.
The renal immune-complex (IC) disease induced in BALB/c mice by subcutaneous injection of mercuric chloride (1.6 mg/kg b.w.) every third day for 8 weeks was prevented by the intraperitoneal injection of cyclophosphamide (20 mg/kg b.w.) 24 h prior to mercury injection. The importance of T-cells in the induction of immune-complex disease was studied. BALB/c mice given drinking water containing 20 mg/l of HgCl2 for 10 weeks showed an increased titre of granular, mesangial IgG deposits and vessel wall IgG deposits. Identically treated, congenic nude BALB/c mice with a similar body burden of mercury developed no IC-disease. Cytophotometric analysis of the T-cell subsets in subcutaneously mercury-treated mice revealed a decrease in the fraction of T-helper (L3T4+) splenic cells in the SJL and C57BL/6J strains; no significant change in the T-cell subsets was found in BALB/c mice. C57BL/6J mice, resistant to induction of IC-disease by mercury, showed no increase in the fraction of T-suppressor/cytotoxic (Lyt-2+) cells and no change in the T-helper/T-suppressor cell ratio. C57BL/6J mice could not be rendered susceptible to mercury-induced IC-disease by treatment with different doses of cyclophosphamide.